Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 07 Jan 2025

KAE ameliorates LPS-mediated acute lung injury by inhibiting PANoptosis through the intracellular DNA-cGAS-STING axis

in Inflammation Pharmacology

Yonghu Chen
Xilin Wu
Zhe Jiang
Xuezheng Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1461931

2,519 views

Original Research

Published on 06 Jan 2025

Glycyrrhizin as a potential disease-modifying therapy for epilepsy: insights into targeting pyroptosis to exert neuroprotective and anticonvulsant effects

in Inflammation Pharmacology

Lei Wei
Sijie Ou
Youshi Meng
Lanfeng Sun
Lin Zhang
Yuling Lu
Yuan Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1530735

1,203 views

Original Research

Published on 24 Dec 2024

Bacteroides fragilis capsular polysaccharide A ameliorates ulcerative colitis in rat by recovering intestinal barrier integrity and restoring gut microbiota

in Inflammation Pharmacology

Yijia Zhong
Xiujuan Chang
Zihan Zhao
Lijun Zheng
Gaobo Kuang
Ping Li
Chenxuexuan Liu
Yuqin Fan
Zhixuan Liang
Ke Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1402465

2,211 views
1 citation

Review

Published on 23 Dec 2024

Platelets as crucial players in the dynamic interplay of inflammation, immunity, and cancer: unveiling new strategies for cancer prevention

in Inflammation Pharmacology

Annalisa Contursi
Stefania Tacconelli
Sara Di Berardino
Alessandra De Michele
Paola Patrignani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1520488

3,413 views
2 citations

Original Research

Published on 23 Dec 2024

Elucidating the mechanism of stigmasterol in acute pancreatitis treatment: insights from network pharmacology and in vitro/in vivo experiments

in Inflammation Pharmacology

Xuanlin Zhao
Fan Li
Ao Wen
Xiuxian Yu
Xinrui Xu
Chengyu Wan
Yu Cao
Guang Xin
Wen Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485915

1,463 views

Original Research

Published on 20 Dec 2024

The endocannabinoid anandamide prevents TH17 programming of activated T lymphocytes while preserving TH1 responses

in Inflammation Pharmacology

Anastasiia Kiprina
Tom Teichmann
Virna Margarita Martín Giménez
Wenqing Xu
Fiona Sailer
Maike Windbergs
Walter Manucha
Andreas Weigert
Ralf P. Brandes

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1528759

1,302 views

Original Research

Published on 19 Dec 2024

Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors

in Inflammation Pharmacology

Yiping Cao
Zhou Wu
Moruo Zhang
Ran Ji
Hongxing Zhang
Lingzhen Song

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1467305

1,318 views
1 citation

Correction

Published on 16 Dec 2024

Corrigendum: Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation

in Inflammation Pharmacology

Jing Lu
Jie Gao
Jing Sun
Haiping Wang
Huijuan Sun
Qian Huang
Yao Zhang
Shuo Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1532774

640 views

Review

Published on 12 Dec 2024

The advent of chimeric antigen receptor T Cell therapy in recalibrating immune balance for rheumatic autoimmune disease treatment

in Inflammation Pharmacology

Qianyu Guo
Jie Li
Juanjuan Wang
Linxin Li
Jia Wei
Liyun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1502298

4,776 views
1 citation

Review

Published on 06 Dec 2024

Decoding ferroptosis: transforming orthopedic disease management

in Inflammation Pharmacology

Guanlin Huo
Yumeng Lin
Lusheng Liu
Yuqi He
Yi Qu
Yang Liu
Renhe Zhu
Bo Wang
Qing Gong
Zhongyu Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1509172

3,028 views
2 citations

Editorial

Published on 04 Dec 2024

Editorial: Recent advances in the pathogenesis and potential biomarkers of fibrosis

in Inflammation Pharmacology

Samar A. Antar
Aymen Halouani
Karim Tawfic
Walied Abdo
Ayman M. Mahmoud
Yassine Sassi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1527123

605 views

Review

Published on 04 Dec 2024

New insights into SUMOylation and NEDDylation in fibrosis

in Inflammation Pharmacology

Jin Han
Jun Wu
Wen-Tao Kou
Li-Na Xie
Ya-Li Tang
Da-Long Zhi
Ping Li
Dan-Qian Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476699

1,982 views

Original Research

Published on 26 Nov 2024

A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα

in Inflammation Pharmacology

Alessandra Ammazzalorso
Stefania Tacconelli
Annalisa Contursi
Ulrika Hofling
Carmen Cerchia
Sara Di Berardino
Alessandra De Michele
Rosa Amoroso
Antonio Lavecchia
Paola Patrignani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488722

1,599 views

Original Research

Published on 21 Nov 2024

Polyvinylalcohol-carbazate mitigates acute lung injury caused by hydrochloric acid

in Inflammation Pharmacology

Caijuan Dong
Jielu Liu
Alessandro Quaranta
Xu Jing
Mu Nie
Craig E. Wheelock
Benjamin Murrell
Jonathan M. Coquet
Tim Melander Bowden
Thomas Engstrand

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503648

1,386 views
1 citation

Correction

Published on 08 Nov 2024

Corrigendum: Efficacy of hyaluronic acid in the treatment of nasal inflammatory diseases: a systematic review and meta-analysis

in Inflammation Pharmacology

Huixia Liu
Yue Chen
Huan Wang
Xinyi Luo
Dengpiao Xie
Qing Ji
Li Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1404434

764 views
1 citation

Review

Published on 07 Nov 2024

Estrogen: the forgotten player in metaflammation

in Inflammation Pharmacology

Bao-Ting Zhu
Qing-Qing Liao
Hai-Ying Tian
Dao-Jiang Yu
Teng Xie
Xi-Lu Sun
Xin-Meng Zhou
Ying-Xuan Han
Yu-Jie Zhao
Mohamed El-Kassas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1478819

3,054 views
4 citations